We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+596.65%
AUM
$438B
AUM Growth
-$46.9M
Cap. Flow
-$1.63B
Cap. Flow %
-0.37%
Top 10 Hldgs %
18.2%
Holding
5,542
New
462
Increased
1,879
Reduced
2,145
Closed
563
Avg Time Held Equity + Options
9 quarters
Top 10 Avg Time Held Equity + Options
10 quarters
Top 20 Avg Time Held Equity + Options
8.6 quarters
Avg Time Held Equity only
9.7 quarters
Top 10 Avg Time Held Equity only
10.9 quarters
Top 20 Avg Time Held Equity only
8.9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.9%
2 Financials 14.86%
3 Technology 11.73%
4 Healthcare 9.66%
5 Consumer Discretionary 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TEVA icon
2251
CALL
Teva Pharmaceutical Industries Limited
TEVA
$45.9B
$5.81M ﹤0.01%
175,000
-125,000
-42% -$3.87M
2017 Q1
1 quarter
QLYS icon
2252
Qualys
QLYS
$6.84B
$5.81M ﹤0.01%
142,480
-35,112
-20% -$1.41M
2014 Q2
12 quarters
GMS
2253
DELISTED
GMS Inc
GMS
$5.81M ﹤0.01%
206,761
+161,950
+361% +$5.43M
2016 Q4
2 quarters
ESLT icon
2254
Elbit Systems
ESLT
$32.5B
$5.81M ﹤0.01%
46,945
+6,966
+17% +$839K
2013 Q2
16 quarters
BLUE
2255
DELISTED
bluebird bio
BLUE
$5.8M ﹤0.01%
4,266
-1,151
-21% -$1.39M
2014 Q3
11 quarters
HT
2256
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$5.79M ﹤0.01%
312,625
+11,055
+4% +$208K
2013 Q2
16 quarters
AEIS icon
2257
Advanced Energy
AEIS
$12.2B
$5.79M ﹤0.01%
89,421
-262,754
-75% -$19.2M
2013 Q2
16 quarters
SFM icon
2258
PUT
Sprouts Farmers Market
SFM
$5.96B
$5.78M ﹤0.01%
+255,000
New +$5.91M
2017 Q2
0 quarters
XYL icon
2259
Xylem
XYL
$24.5B
$5.78M ﹤0.01%
104,299
-396,325
-79% -$20.6M
2013 Q2
16 quarters
MZTI
2260
The Marzetti Company
MZTI
$2.73B
$5.77M ﹤0.01%
47,079
-6,212
-12% -$778K
2014 Q3
11 quarters
AMT icon
2261
CALL
American Tower
AMT
$76.7B
$5.77M ﹤0.01%
43,600
+15,200
+54% +$1.95M
2017 Q1
1 quarter
BBWI icon
2262
PUT
Bath & Body Works
BBWI
$3.6B
$5.77M ﹤0.01%
132,359
+84,487
+176% +$3.46M
2017 Q1
1 quarter
CBRL icon
2263
Cracker Barrel
CBRL
$1.26B
$5.76M ﹤0.01%
34,465
-206
-0.6% -$33.5K
2013 Q2
16 quarters
TGE
2264
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$5.7M ﹤0.01%
224,281
-24,155
-10% -$637K
2016 Q1
5 quarters
SEMG
2265
DELISTED
SEMGROUP CORPORATION
SEMG
$5.68M ﹤0.01%
210,220
-3,685
-2% -$115K
2013 Q2
16 quarters
BIO icon
2266
Bio-Rad Laboratories Class A
BIO
$9.96B
$5.67M ﹤0.01%
25,032
+15,374
+159% +$3.35M
2013 Q2
16 quarters
LSXMK
2267
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$5.66M ﹤0.01%
178,248
+176,423
+9,667% +$5.29M
2016 Q2
4 quarters
TCOM icon
2268
PUT
Trip.com Group
TCOM
$24.1B
$5.66M ﹤0.01%
105,000
-76,660,728
-100% -$4.06B
2016 Q1
5 quarters
SGOL icon
2269
abrdn Physical Gold Shares ETF
SGOL
$6.96B
$5.65M ﹤0.01%
469,020
-1,590
-0.3% -$19.4K
2013 Q2
16 quarters
WCC
2270
WESCO International
WCC
$18.9B
$5.65M ﹤0.01%
98,587
-276,202
-74% -$17.1M
2013 Q2
16 quarters
UAL icon
2271
CALL
United Airlines
UAL
$36.6B
$5.64M ﹤0.01%
75,000
+67,084
+847% +$5.07M
2014 Q3
11 quarters
TVRD
2272
Tvardi Therapeutics
TVRD
$15.2M
$5.63M ﹤0.01%
10,171
+540
+6% +$343K
2014 Q1
13 quarters
ERF
2273
DELISTED
Enerplus Corporation
ERF
$5.63M ﹤0.01%
692,789
+240,997
+53% +$1.9M
2015 Q3
7 quarters
ANDV
2274
PUT
DELISTED
Andeavor
ANDV
$5.62M ﹤0.01%
+60,000
New +$5.06M
2017 Q2
0 quarters
ARCO icon
2275
Arcos Dorados Holdings
ARCO
$1.72B
$5.59M ﹤0.01%
771,221
-260,737
-25% -$2.11M
2015 Q4
6 quarters

Similar funds

JP Morgan Chase's Q2 2017 Portfolio in Review

As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.

By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

  • JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
  • JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
  • JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
  • JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
  • JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
  • JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
  • JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.